|
Press Releases |
|
 |
|
Tuesday, October 2, 2012 |
|
The Natural Resource Prospects for Private Wealth Managers |
Agriculture, energy and mining are positioned to benefit from the continued urbanisation of emerging nations, however, in the current "China centric" market many are trading at large discounts to their net present value. This is presenting an incredible opportunity for investors, says Clive Landale, Managing Director, 90 West Asset Management Ltd. more info >> |
|
Wednesday, September 26, 2012 |
|
Quality Investments Will Produce Quality Returns |
In the next decade, asset allocation should be separated into five-year periods as each will have its own negative and positive returns, says Gina Sanchez, Director of Equity & Asset Allocation Strategy, Roubini Global Economics. more info >> |
|
What it Takes to be a Better CFO |
Chief Financial Officers (CFOs) should not be afraid to ask questions to the experts in the field, advises Melanie Mailly-Demont, Chief Financial Officer, Infilco Degremont. more info >> |
|
Monday, September 24, 2012 |
|
Making Hotel Conversions Work for the Brand |
Converting ageing properties into hotels has always been an attractive option for hoteliers, but in today's economy, it is proving to be a much faster and easier way of creating a brand presence in a specific market, says Sary Arab, COO, Nikki Beach EMEA Hotels & Resorts. more info >> |
|
Tuesday, September 25, 2012 |
|
The Value of a Legal One-Stop Shop in the Middle East |
"None of the large international law firms have a diversified network of offices in the Middle East like we do or are able to give clients a one-stop shop for legal services like we can," said Rolf Meyer-Reumann, Partner, Meyer-Reumann & Partners. more info >> |
|
Tuesday, April 17, 2012 |
|
Finding Value in the Australian Industrial Real Estate Market |
Matthew Gibb from Gibb Group, a property development and management company at the marcus evans APAC Investments Summit 2012, on the real estate investing opportunities available in Australia. more info >> |
|
Monday, April 16, 2012 |
|
Pricing Products for Success in the Pharmaceutical Industry |
Pharmaceutical companies are not maximizing their pricing power and opportunities, says Mick Kolassa, Chairman & Managing Partner, Medical Marketing Economics LLC. more info >> |
|
Friday, April 13, 2012 |
|
Minimizing the Effects of Underinvestment in Water Utilities |
Nilaksh Kothari, a speaker at marcus evans Water & Wastewater Management Summit 2012, talks on overcoming the challenges being faced at water utilities. more info >> |
|
Thursday, April 12, 2012 |
|
Pharmaceutical Marketing Before Loss of Exclusivity |
Tom Lawrence of Meta Pharmaceutical Services LLC, a solution provider company at the marcus evans PharmaMarketing Summit 2012, talks on marketing mature pharmaceutical brands. more info >> |
|
Compirion Hospital Solutions: Targeting Patient Satisfaction and Operational Efficiency |
Spencer Tepper from Compirion Hospital Solutions LLC, a solution provider company at the marcus evans National Healthcare CXO Summit Spring 2012, on increasing patient satisfaction and operational efficiency within the healthcare environment. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
|
|
|
GTJAI Achieved 'Carbon Neutrality' at Operational Level for the Third Consecutive Year
Jul 29, 2025 13:15 HKT/SGT
|
|
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
Jul 29, 2025 12:30 JST
|
|
|
宇樹衝刺IPO、機械人應用加速落地:首程控股雙輪驅動兌現紅利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇树冲刺IPO、机器人应用加速落地:首程控股双轮驱动兑现红利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
國泰君安國際連續第三年實現營運層面「碳中和」
Jul 29, 2025 11:19 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 9:01 JST
|
|
|
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 05:00: JST
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT/SGT
|
|
|
HKTDC boosts Hong Kong's competitive edge in high-value services
Jul 28, 2025 23:30 HKT/SGT
|
|
|
Intelligent Tech Unlocks the Future - Connecting the World, CITIC Telecom Unveils Future-ready Solutions at WAIC 2025
Jul 28, 2025 23:16 HKT/SGT
|
|
|
Phoenitron Grants Share Options and Sets HK$75 Million Profit Target for First Three Quarters
Jul 28, 2025 23:08 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 21:00: JST
|
|
|
|
More News >> |
|
|
|
|
|